{"schema_version":"secwatch.filing_event.v1","accession":"0001564590-22-022228","form_type":"8-K","ticker":"XENE","cik":"0001582313","company_name":"Xenon Pharmaceuticals Inc.","filed_at":"2022-06-02T23:59:59+00:00","discovered_at":"2026-05-14T18:04:01.311384+00:00","generated_at":"2026-06-25T05:08:39.622108+00:00","sec_items":["5.02","5.07","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Xenon shareholders approve 5.3M share equity plan increase; all director nominees elected","bullets":["Amendment to 2014 Equity Plan approved: 35.6M for, 6.2M against, 5.1M broker non-votes.","Total share reserve under plan increased to ~13.37M shares (includes prior reserves and 5.3M addition).","All eight director nominees elected with strong majority (e.g., Simon Pimstone 40.9M for).","Say-on-pay advisory vote passed: 41.1M for, 0.6M against.","KPMG reappointed as auditor with 45.9M for, 1.0M withheld."],"urls":{"canonical":"https://secwatch.observer/filing/0001564590-22-022228","json":"https://secwatch.observer/filing/0001564590-22-022228.json","markdown":"https://secwatch.observer/filing/0001564590-22-022228.md","text":"https://secwatch.observer/filing/0001564590-22-022228.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1582313/000156459022022228/0001564590-22-022228-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1582313/000156459022022228/xene-8k_20220601.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-25T05:08:39.622108+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}